Kaneka Medical America is the lead sponsor of 4 current clinical trials in our USA register. 2 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Focal Segmental Glomerulosclerosis.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
NCT04065438 · ClinicalTrials.gov ↗ · Focal Segmental Glomerulosclerosis
|
Not applicable | Recruiting | 2020-01 | USA |
|
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
NCT02235857 · ClinicalTrials.gov ↗ · Focal Segmental Glomerulosclerosis
|
Not applicable | Recruiting | 2015-05 | USA |
|
Prospective Multi-center Single Arm Study for Subjects With Chronic Subdural Hematoma Treated With i-ED COILs, Either Alone or in Combination With Burr-holes or Mini-craniotomy
NCT07214623 · ClinicalTrials.gov ↗ · Chronic Subdural Hematoma, cSDH, Chronic Subdural Hematomas
|
Observational | Not yet open | 2025-11 | USA |
|
Kaneka Endovascular Embolization and Protection
NCT05563051 · ClinicalTrials.gov ↗ · Aneurysm Cerebral
|
Not applicable | Active, closed | 2022-12 | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 4 | 2 |
A trial with sites in more than one country appears in each of those registers.
| Sponsor | Trials |
|---|---|
| Travere Therapeutics | 2 |
Sponsors with the most current trials registered for this condition.
Kaneka Medical America is the lead sponsor of 4 current trials on ClinicalTrials.gov in our USA register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.
Yes. 2 of its 4 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.